Autophagy Dysfunction: The Kernel of Hair Loss?
DOI: https://doi.org/10.2147/ccid.s462294
2024-05-21
Clinical Cosmetic and Investigational Dermatology
Abstract:Xiaofan Jin, 1 Xiuzu Song 2 1 Zhejiang University School of Medicine, Department of Dermatology, Hangzhou Third People's Hospital, Affiliated Hangzhou Dermatology Hospital, Hangzhou, People's Republic of China; 2 Department of Dermatology, Hangzhou Third People's Hospital, Affiliated Hangzhou Dermatology Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of China Correspondence: Xiuzu Song, Department of Dermatology, Hangzhou Third People's Hospital, Affiliated Hangzhou Dermatology Hospital, Zhejiang University School of Medicine, Westlake Ave 38, Hangzhou, 310009, People's Republic of China, Email Autophagy is recognized as a crucial regulatory process, instrumental in the removal of senescent, dysfunctional, and damaged cells. Within the autophagic process, lysosomal digestion plays a critical role in the elimination of impaired organelles, thus preserving fundamental cellular metabolic functions and various biological processes. Mitophagy, a targeted autophagic process that specifically focuses on mitochondria, is essential for sustaining cellular health and energy balance. Therefore, a deep comprehension of the operational mechanisms and implications of autophagy and mitophagy is vital for disease prevention and treatment. In this context, we examine the role of autophagy and mitophagy during hair follicle cycles, closely scrutinizing their potential association with hair loss. We also conduct a thorough review of the regulatory mechanisms behind autophagy and mitophagy, highlighting their interaction with hair follicle stem cells and dermal papilla cells. In conclusion, we investigate the potential of manipulating autophagy and mitophagy pathways to develop innovative therapeutic strategies for hair loss. Keywords: hair follicle, mitophagy, dermal papilla cell, hair follicle stem cell, alopecia The term "hair loss" refers to the gradual diminution or shedding of hair. Alopecia constitutes a multifaceted condition influenced by an array of factors such as genetics, physiology, environment, and lifestyle choices. 1,2 Alopecia transcends a mere physical concern; it alters appearance and can exert a profound impact on psychological well-being and social interactions. To elaborate, in 2014, over one million individuals sought surgical or non-surgical therapy. 3 In 2015, the global market for hair loss treatments was appraised at approximately $7.3 billion. 3 Nestled within the dermis and subcutaneous tissue, the hair follicle (HF) emerges as a complex organ embodying intricate structures and functions. 4 It houses over twenty distinct cell types that orchestrate HF cycling and hair proliferation, with the dermal papilla cell (DPC) and the HF stem cell (HFSC) playing leading roles. 5 HF cycling can be segmented into three principal stages: anagen, catagen, and telogen. 6 During the transition from late telogen to anagen phases, the interplay between DPC situated in the base of the bulge and stem cells within the bulge region is vital. 7 DPCs dispense an assortment of pro-hair growth factors, pivotal for the activation of stem cells and the commencement of a new hair cycle. 8,9 Upon signal reception, activated HFSCs proliferate until a critical population threshold is met, instigating the HF's ensuing growth phase. 10 Nevertheless, multiple factors can perturb the HF cycle, engendering a premature exit from the anagen phase and an expedited arrival of catagen and telogen stages. Outcomes like hair shaft (HS) miniaturization or a reduction in the quantity of HFs during the catagen-telogen phase potentially culminate in hair loss attributable to these malfunctions. 11 Androgenetic alopecia (AGA), colloquially termed male pattern hair loss (MPHL) or female pattern hair loss (FPHL), reigns as the preeminent form of hair loss worldwide. 12 In men, it starts with bilateral temporal thinning of the frontal scalp and progresses to the vertex. 13 In women, it predominantly manifests as diffuse thinning atop the scalp, sans a receding hairline 14 The etiology of AGA remains incompletely deciphered, yet is principally correlated with the male hormone testosterone and its metabolite dihydrotestosterone (DHT). These hormones precipitate the miniaturization of HFs, culminating in a truncated hair growth cycle and progressive hair thinning that inexorably leads to hair loss. 15,16 Typically, on an average scalp, between 90–95% of HFs are in the anagen phase. 17 Nevertheless, in individuals afflicted by AGA, a pronounced surge in telogen follicles is observed, accounting for roughly 20% of HFs in the telogen phase, with a mere 80% remaining in the anagen phase. As of now, hair transplantation and pharma -Abstract Truncated-
dermatology